TCL Archive Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer March 26, 2010
TCL Archive NCI’s Independence To Be Challenged By Edwards When Cancer Act Comes Up For Renewal Next Year December 21, 1973
TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
